MyFinsight
Home
Blog
About
Back
Income Statement
Enliven Therapeutics, Inc. (ELVN)
Enliven Therapeutics, Inc. (ELVN)
source: myfinsight.com
Comprehensive loss
-$34,008K
(-33.39%↓ Y/Y)
Interest income
$4,732K
(45.56%↑ Y/Y)
Net loss
-$32,485K
(-28.22%↓ Y/Y)
Net unrealized
gaines on marketable...
-$1,523K
(-845.96%↓ Y/Y)
Total other income
(expense), net
$4,724K
(45.40%↑ Y/Y)
Other expense
-$8K
(-300.00%↓ Y/Y)
Loss from operations
-$37,209K
(-30.17%↓ Y/Y)
Total operating
expenses
$37,209K
(30.17%↑ Y/Y)
Research and development
$28,996K
(34.92%↑ Y/Y)
General and
administrative
$8,213K
(15.79%↑ Y/Y)
Back